Literature DB >> 17928249

Exploring QSTR and toxicophore of hERG K+ channel blockers using GFA and HypoGen techniques.

Divita Garg1, Tamanna Gandhi, C Gopi Mohan.   

Abstract

Predictive quantitative structure-toxicity and toxicophore models were developed for a diverse series of hERG K+ channel blockers, acting as anti-arrhythmic agents using QSAR+ module in Cerius2 and HypoGen module in Catalyst software, respectively. The 2D-QSTR analysis has been performed on a dataset of 68 molecules carefully selected from literature for which IC50 values measured on hERG K+ channels expressed in mammalian cells lines using the voltage patch clamp assay technique were reported. Their biological data, expressed as IC50, spanned from 7.0nM to 1.4mM, with 7 orders difference. Several types of descriptors including electrotopological, thermodynamic, ADMET, graph theoretical (topological and information content) were used to derive a quantitative relationship between the channel blockers and its physico-chemical properties. Statistically significant QSTR model was obtained using genetic function approximation methodology, having seven descriptors, with a correlation coefficient (r2) of 0.837, cross-validated correlation coefficient (q2) of 0.776 and predictive correlation coefficient (r2 pred) of 0.701, indicating the robustness of the model. Toxicophore model generated using HypoGen module in Catalyst, on these datasets, showed three important features for hERG K+ channel blockers, (i) hydrophobic group (HP), (ii) ring aromatic group (RA) and (iii) hydrogen bond acceptor lipid group (HBAl). The most predictive hypothesis (Hypo 1), consisting of these three features had a best correlation coefficient of 0.820, a low rms deviation of 1.740, and a high cost difference of 113.50, which represents a true correlation and a good predictivity. The hypothesis, Hypo 1 was validated by a test set consisting of 12 molecules and by a cross-validation of 95% confidence level. Accordingly, our 2D-QSTR and toxicophore model has strong predictivity to identify structurally diverse hERG K+ channel blockers with desired biological activity. These models provide a useful framework for understanding binding, and gave structural insight into the specific protein-ligand interactions responsible for affinity, and how one might modify any given structure to mitigate binding.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17928249     DOI: 10.1016/j.jmgm.2007.08.002

Source DB:  PubMed          Journal:  J Mol Graph Model        ISSN: 1093-3263            Impact factor:   2.518


  9 in total

Review 1.  Computational methods in drug discovery.

Authors:  Gregory Sliwoski; Sandeepkumar Kothiwale; Jens Meiler; Edward W Lowe
Journal:  Pharmacol Rev       Date:  2013-12-31       Impact factor: 25.468

2.  Predicting the potency of hERG K⁺ channel inhibition by combining 3D-QSAR pharmacophore and 2D-QSAR models.

Authors:  Yayu Tan; Yadong Chen; Qidong You; Haopeng Sun; Manhua Li
Journal:  J Mol Model       Date:  2011-06-10       Impact factor: 1.810

3.  Development, validation, and use of quantitative structure-activity relationship models of 5-hydroxytryptamine (2B) receptor ligands to identify novel receptor binders and putative valvulopathic compounds among common drugs.

Authors:  Rima Hajjo; Christopher M Grulke; Alexander Golbraikh; Vincent Setola; Xi-Ping Huang; Bryan L Roth; Alexander Tropsha
Journal:  J Med Chem       Date:  2010-11-11       Impact factor: 7.446

4.  Tuning HERG out: antitarget QSAR models for drug development.

Authors:  Rodolpho C Braga; Vinicius M Alves; Meryck F B Silva; Eugene Muratov; Denis Fourches; Alexander Tropsha; Carolina H Andrade
Journal:  Curr Top Med Chem       Date:  2014       Impact factor: 3.295

5.  Ligand-based molecular design of 4-benzylpiperidinealkylureas and amides as CCR3 antagonists.

Authors:  Vaibhav Jain; Ashish Pandey; Shikhar Gupta; C Gopi Mohan
Journal:  J Mol Model       Date:  2009-12-04       Impact factor: 1.810

6.  Comparative molecular field analysis and comparative molecular similarity indices analysis of hydroxyethylamine derivatives as selective human BACE-1 inhibitor.

Authors:  Ashish Pandey; Jignesh Mungalpara; C Gopi Mohan
Journal:  Mol Divers       Date:  2009-03-28       Impact factor: 2.943

7.  Pharmacophore Based Virtual Screening Approach to Identify Selective PDE4B Inhibitors.

Authors:  Anand Gaurav; Vertika Gautam
Journal:  Iran J Pharm Res       Date:  2017       Impact factor: 1.696

8.  Experimentally Validated Pharmacoinformatics Approach to Predict hERG Inhibition Potential of New Chemical Entities.

Authors:  Saba Munawar; Monique J Windley; Edwin G Tse; Matthew H Todd; Adam P Hill; Jamie I Vandenberg; Ishrat Jabeen
Journal:  Front Pharmacol       Date:  2018-09-19       Impact factor: 5.810

Review 9.  On modeling and utilizing chemical compound information with deep learning technologies: A task-oriented approach.

Authors:  Sangsoo Lim; Sangseon Lee; Yinhua Piao; MinGyu Choi; Dongmin Bang; Jeonghyeon Gu; Sun Kim
Journal:  Comput Struct Biotechnol J       Date:  2022-08-05       Impact factor: 6.155

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.